Enzon Pharmaceuticals Inc (ENZN)
0.0785
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Enzon Pharmaceuticals Market Cap: 5.826M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 5.826M |
| May 03, 2024 | 5.566M |
| May 02, 2024 | 5.566M |
| May 01, 2024 | 6.293M |
| April 30, 2024 | 6.193M |
| April 29, 2024 | 6.193M |
| April 26, 2024 | 6.193M |
| April 25, 2024 | 6.531M |
| April 24, 2024 | 5.786M |
| April 23, 2024 | 5.786M |
| April 22, 2024 | 5.370M |
| April 19, 2024 | 5.370M |
| April 18, 2024 | 5.370M |
| April 17, 2024 | 5.370M |
| April 16, 2024 | 4.809M |
| April 15, 2024 | 5.551M |
| April 12, 2024 | 7.036M |
| April 11, 2024 | 7.036M |
| April 10, 2024 | 7.036M |
| April 09, 2024 | 6.854M |
| April 08, 2024 | 5.915M |
| April 05, 2024 | 5.195M |
| April 04, 2024 | 5.195M |
| April 03, 2024 | 4.824M |
| April 02, 2024 | 4.601M |
| Date | Value |
|---|---|
| April 01, 2024 | 5.807M |
| March 28, 2024 | 7.013M |
| March 27, 2024 | 7.013M |
| March 26, 2024 | 6.271M |
| March 25, 2024 | 5.344M |
| March 22, 2024 | 5.195M |
| March 21, 2024 | 5.937M |
| March 20, 2024 | 5.195M |
| March 19, 2024 | 4.453M |
| March 18, 2024 | 6.145M |
| March 15, 2024 | 6.145M |
| March 14, 2024 | 6.145M |
| March 13, 2024 | 6.201M |
| March 12, 2024 | 6.308M |
| March 11, 2024 | 5.195M |
| March 08, 2024 | 5.195M |
| March 07, 2024 | 5.956M |
| March 06, 2024 | 5.759M |
| March 05, 2024 | 6.145M |
| March 04, 2024 | 4.831M |
| March 01, 2024 | 5.759M |
| February 29, 2024 | 4.846M |
| February 28, 2024 | 5.113M |
| February 27, 2024 | 5.937M |
| February 26, 2024 | 6.308M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.453M
Minimum
Mar 19 2024
61.97M
Maximum
Feb 08 2021
18.40M
Average
14.11M
Median
May 05 2023
Market Cap Benchmarks
| AIM ImmunoTech Inc | 21.21M |
| Perspective Therapeutics Inc | 1.083B |
| Protalix BioTherapeutics Inc | 83.28M |
| Electromed Inc | 157.30M |
| Armata Pharmaceuticals Inc | 103.38M |
Market Cap Related Metrics
| Price to Book Value | 1.662 |
| Price to Free Cash Flow | 4.464 |
| Price | 0.0785 |
| Earnings Yield | -0.89% |